Literature DB >> 6171240

Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage.

K T Chong, J J Gould, C A Mims.   

Abstract

Two strains of mouse cytomegalovirus (MCMV) propagated in mouse salivary glands could be distinguished in neutralization tests. Cell (mouse embryo fibroblast)-passaged virus of either strain was generally 10-20 times easier to neutralize than virus produced in mouse salivary glands. Evidence was obtained that mouse immunoglobulin was attached to virus particles in salivary gland preparations. First, antibody to mouse immunoglobulin inactivated salivary gland virus but not cell culture-grown virus. Second, virus obtained from mice early after infection, before antibody production, was as easy to neutralize as cell culture-grown virus. The attached immunoglobulins were CMV-specific, non-neutralizing, and interfered with the action of neutralizing antibody. Non-neutralizing antibodies that bind to infectious virus particles are present in mouse serum at the time salivary glands are harvested, 3 weeks after infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171240     DOI: 10.1007/BF01315153

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  15 in total

1.  MOUSE CYTOMEGALOVIRUS INFECTION. II. OBSERVATIONS DURING PROLONGED INFECTIONS.

Authors:  D N MEDEARIS
Journal:  Am J Hyg       Date:  1964-07

2.  Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus.

Authors:  C A Mims; J Gould
Journal:  J Med Microbiol       Date:  1979-02       Impact factor: 2.472

3.  Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera.

Authors:  J L Waner; T H Weller
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

4.  Comparative studies of the Smith and Raynaud strains of murine cytomegalovirus.

Authors:  K S Kim; V Sapienza; R I Carp
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

5.  Immunosuppression during acute murine cytomegalovirus infection.

Authors:  J E Osborn; A A Blazkovec; D L Walker
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

6.  Neutralization of sensitized lactic dehydrogenase virus by anti-gammglobulin.

Authors:  A L Notkins; M Mage; W K Ashe; S Mahar
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

7.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

8.  Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody.

Authors:  K S Kim; R I Carp
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

9.  Virulence and attenuation of murine cytomegalovirus.

Authors:  J E Osborn; D L Walker
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

10.  Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity.

Authors:  K T Chong; C A Mims
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

View more
  9 in total

Review 1.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

2.  Virulence characteristics of murine cytomegalovirus in cell and organ cultures.

Authors:  M C Jordan; J L Takagi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

3.  Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays.

Authors:  D C Classen; J M Morningstar; J D Shanley
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Rodent Models of Congenital Cytomegalovirus Infection.

Authors:  Berislav Lisnić; Jelena Tomac; Djurdjica Cekinović; Stipan Jonjić; Vanda Juranić Lisnić
Journal:  Methods Mol Biol       Date:  2021

5.  Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids.

Authors:  R M Ravindranath; M C Graves
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression.

Authors:  I S El-Amouri; M Bani-Ahmad; Y Tang-Feldman; F Lin; C Ko; C Pomeroy; O R Oakley
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

7.  A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection.

Authors:  Mark J Pilgrim; Laura Kasman; Jasvir Grewal; Mary E Bruorton; Phil Werner; Lucille London; Steven D London
Journal:  Exp Mol Pathol       Date:  2007-01-12       Impact factor: 3.362

8.  Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings.

Authors:  Joseph W Jackson; Trevor J Hancock; Pranay Dogra; Ravi Patel; Ravit Arav-Boger; Angela D Williams; Stephen J Kennel; Jonathan S Wall; Tim E Sparer
Journal:  mSphere       Date:  2019-02-13       Impact factor: 4.389

9.  MCMV Centrifugal Enhancement: A New Spin on an Old Topic.

Authors:  Trevor J Hancock; Morgan Lynn Hetzel; Andrea Ramirez; Tim E Sparer
Journal:  Pathogens       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.